NASDAQ:OCSL - Oaktree Specialty Lending Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $5.20
  • Forecasted Upside: -14.89 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$6.11
▼ -0.07 (-1.13%)
1 month | 3 months | 12 months
Get New Oaktree Specialty Lending Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OCSL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OCSL

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$5.20
▼ -14.89% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Oaktree Specialty Lending in the last 3 months. The average price target is $5.20, with a high forecast of $5.75 and a low forecast of $4.75. The average price target represents a -14.89% upside from the last price of $6.11.
Buy
The current consensus among 5 contributing investment analysts is to buy stock in Oaktree Specialty Lending. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/2/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/31/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/29/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/27/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/26/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/25/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/17/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$4.75 ➝ $5.50Low
i
6/19/2020Janney Montgomery ScottUpgradeNeutral ➝ Buy$5.00High
i
5/11/2020Wells Fargo & CompanyBoost Price TargetOverweight$4.00 ➝ $5.00Low
i
Rating by Finian O'Shea at Wells Fargo & Company
5/11/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$6.25 ➝ $4.75Low
i
5/10/2020Wells Fargo & CompanyReiterated RatingBuyLow
i
Rating by Finian O'Shea at Wells Fargo & Company
5/8/2020Keefe, Bruyette & WoodsBoost Price TargetOutperform$4.50 ➝ $4.75High
i
4/27/2020Wells Fargo & CompanyBoost Price TargetOverweight$3.75 ➝ $4.00Medium
i
Rating by Finian O'Shea at Wells Fargo & Company
3/25/2020Wells Fargo & CompanyLower Price TargetOverweight$6.00 ➝ $3.75Low
i
Rating by Finian O'Shea at Wells Fargo & Company
3/5/2020National SecuritiesInitiated CoverageBuy$5.75Medium
i
1/15/2020Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$6.00Low
i
10/10/2019Jefferies Financial GroupInitiated CoverageBuy$6.50Medium
i
7/29/2019Janney Montgomery ScottInitiated CoverageNeutral ➝ NeutralLow
i
5/13/2019National SecuritiesReiterated RatingBuy$7.00Low
i
Rating by Christopher Testa at National Securities
2/7/2019National SecuritiesUpgradeNeutral ➝ Buy$5.00 ➝ $7.00High
i
12/17/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$5.50 ➝ $5.75Low
i
12/3/2018National SecuritiesReiterated RatingNeutral$5.00Low
i
8/21/2018Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ OutperformHigh
i
Rating by Ryan Lynch at Keefe, Bruyette & Woods
8/13/2018National SecuritiesReiterated RatingNeutral$5.00Low
i
8/10/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$5.00 ➝ $5.50Low
i
8/10/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$4.00 ➝ $5.00Low
i
8/8/2018Keefe, Bruyette & WoodsSet Price TargetHold$6.00Low
i
Rating by Ryan Lynch at Keefe, Bruyette & Woods
7/31/2018JMP SecuritiesReiterated RatingBuy$5.50Low
i
5/9/2018National SecuritiesReiterated RatingNeutral$5.00Medium
i
2/12/2018BMO Capital MarketsLower Price TargetMarket Perform$5.00 ➝ $4.00Low
i
2/12/2018National SecuritiesReiterated RatingNeutral$5.00Low
i
2/9/2018Keefe, Bruyette & WoodsSet Price TargetHold$5.00Low
i
Rating by Ryan Lynch at Keefe, Bruyette & Woods
2/6/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$6.00Low
i
1/8/2018BMO Capital MarketsReiterated RatingHold$5.00N/A
i
12/26/2017Maxim GroupReiterated RatingHoldLow
i
12/1/2017National SecuritiesDowngradeBuy ➝ Neutral$7.00 ➝ $5.00Low
i
11/30/2017Keefe, Bruyette & WoodsSet Price TargetHold$6.00Low
i
Rating by Ryan Lynch at Keefe, Bruyette & Woods
11/1/2017JPMorgan Chase & Co.Boost Price TargetNeutral$5.50 ➝ $6.00N/A
i
10/16/2017Keefe, Bruyette & WoodsReiterated RatingHold$6.00N/A
i
10/6/2017BMO Capital MarketsReiterated RatingHold$4.00N/A
i
8/14/2017National SecuritiesReiterated RatingBuy$7.00Medium
i
8/10/2017Maxim GroupReiterated RatingHoldLow
i
7/18/2017National SecuritiesUpgradeNeutral ➝ Buy$4.00 ➝ $7.00Medium
i
7/18/2017Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$4.75 ➝ $6.00Medium
i
7/17/2017JMP SecuritiesUpgradeMarket Perform ➝ Outperform$6.50Medium
i
6/30/2017Keefe, Bruyette & WoodsReiterated RatingHold$4.75Low
i
5/15/2017National SecuritiesReiterated RatingNeutral$4.00Low
i
5/15/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$5.50 ➝ $4.75Low
i
5/10/2017Keefe, Bruyette & WoodsSet Price TargetHold$5.00Low
i
4/11/2017BMO Capital MarketsReiterated RatingHold$4.00Low
i
3/30/2017Raymond JamesReiterated RatingMarket Perform ➝ UnderperformMedium
i
2/14/2017BarclaysSet Price TargetHold$5.00N/A
i
2/13/2017National SecuritiesLower Price TargetNeutral$6.00 ➝ $4.00N/A
i
12/1/2016BarclaysSet Price TargetHold$6.00N/A
i
12/1/2016National SecuritiesReiterated RatingNeutral$6.00N/A
i
8/16/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$6.75 ➝ $6.50N/A
i
8/11/2016National SecuritiesReiterated RatingNeutral$6.00N/A
i
5/31/2016Wells Fargo & CompanyReiterated RatingHoldN/A
i
5/24/2016Maxim GroupDowngradeBuy ➝ HoldN/A
i
5/12/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$7.50 ➝ $6.75N/A
i
5/12/2016National SecuritiesReiterated RatingNeutral$7.00 ➝ $6.00N/A
i
(Data available from 2/26/2016 forward)
Oaktree Specialty Lending logo
Oaktree Specialty Lending Corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, and management buyouts in small and mid-sized companies. The fund seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering, and media and advertising sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies with enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.
Read More

Today's Range

Now: $6.11
$6.06
$6.21

50 Day Range

MA: $5.87
$5.56
$6.23

52 Week Range

Now: $6.11
$2.33
$6.27

Volume

565,000 shs

Average Volume

660,462 shs

Market Capitalization

$861.27 million

P/E Ratio

21.82

Dividend Yield

7.12%

Beta

1.45

Frequently Asked Questions

What sell-side analysts currently cover shares of Oaktree Specialty Lending?

The following Wall Street sell-side analysts have issued stock ratings on Oaktree Specialty Lending in the last twelve months: Deutsche Bank Aktiengesellschaft, Janney Montgomery Scott, Keefe, Bruyette & Woods, National Securities, TheStreet, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for OCSL.

What is the current price target for Oaktree Specialty Lending?

5 Wall Street analysts have set twelve-month price targets for Oaktree Specialty Lending in the last year. Their average twelve-month price target is $5.20, suggesting a possible downside of 14.9%. National Securities has the highest price target set, predicting OCSL will reach $5.75 in the next twelve months. Keefe, Bruyette & Woods has the lowest price target set, forecasting a price of $4.75 for Oaktree Specialty Lending in the next year.
View the latest price targets for OCSL.

What is the current consensus analyst rating for Oaktree Specialty Lending?

Oaktree Specialty Lending currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OCSL will outperform the market and that investors should add to their positions of Oaktree Specialty Lending.
View the latest ratings for OCSL.

What other companies compete with Oaktree Specialty Lending?

How do I contact Oaktree Specialty Lending's investor relations team?

Oaktree Specialty Lending's physical mailing address is 333 SOUTH GRAND AVENUE 28TH FLOOR, LOS ANGELES CA, 90071. The credit services provider's listed phone number is 213-830-6300 and its investor relations email address is [email protected] The official website for Oaktree Specialty Lending is www.oaktreespecialtylending.com.